SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-042608
Filing Date
2019-11-12
Accepted
2019-11-12 08:16:19
Documents
17
Period of Report
2019-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20191111.htm   iXBRL 8-K 47005
2 EX-99.1 fgen-ex991_6.htm EX-99.1 365688
3 EX-99.2 fgen-ex992_142.htm EX-99.2 116170
4 GRAPHIC gfo20dp4oa1x000003.jpg GRAPHIC 15837
5 GRAPHIC gfo20dp4oa1x000002.jpg GRAPHIC 18252
6 GRAPHIC gfo20dp4oa1x000001.jpg GRAPHIC 15837
  Complete submission text file 0001564590-19-042608.txt   774050

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA fgen-20191111.xsd EX-101.SCH 5968
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20191111_lab.xml EX-101.LAB 18732
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20191111_pre.xml EX-101.PRE 11173
19 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20191111_htm.xml XML 3404
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 191206302
SIC: 2834 Pharmaceutical Preparations